Fig. 3From: Microangiopathic hemolytic anemia associated with metastatic breast cancer: case report and literature reviewTransition of Tumor marker was linked with the treatment effect. EC epirubicin + cyclophosphamide, LET letrozole, PTX paclitaxelBack to article page